World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 19 February 2015
Main ID:  NCT02327780
Date of registration: 24/12/2014
Prospective Registration: Yes
Primary sponsor: Tel-Aviv Sourasky Medical Center
Public title: The Effectivness of FODMAP Diet in Israel in Relieving Symptoms of Patients With Irritable Bowel Syndrome
Scientific title: The Effectivness of FODMAP Diet in Israel in Relieving Symptoms of Patients With Irritable Bowel Syndrome
Date of first enrolment: January 2015
Target sample size: 40
Recruitment status: Not yet recruiting
URL:  http://clinicaltrials.gov/show/NCT02327780
Study type:  Interventional
Study design:  Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care  
Phase:  N/A
Countries of recruitment
Israel
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

1. Fulfillment of the Rome III criteria for IBS.

2. Aged 18-77 years at the time of screening.

3. Provision of written informed consent.

4. Commitment of availability throughout the 10 week study period.

5. Availability of at least one GI imaging study during the last 5 years (colonoscopy,
sigmoidosopy, abdominal ultrasonography, barium enema) for subjects older than 50
years.

Exclusion Criteria:

1. Major abdominal surgery in the past.

2. The presence of any active (organic) GI disease.

3. Past or present major medical or psychiatric illness.

4. Any concomitant disease.

5. Alarming symptoms (rectal bleeding, weight loss, etc.)

6. Pregnancy.

7. Family history of colorectal carcinoma or IBD, under the age of 50.

8. Abnormal laboratory studies (blood biochemistry, liver enzymes, complete blood
count), abnormal thyroid function.

9. Non-adjusted diet in the case of lactose or gluten intolerance.

10. Recent travel to regions with endemic parasitic diseases.



Age minimum: 18 Years
Age maximum: 77 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Irritable Bowel Syndrome
Intervention(s)
Other: FODMAP diet
Primary Outcome(s)
IBS quality of life score [Time Frame: 9 weeks]
Irritable Bowel Syndrome (IBS) severity score [Time Frame: 9 weeks]
Secondary Outcome(s)
Secondary ID(s)
407-14-TLV
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history